INTA's mission is to democratize biomedical diagnostics, making it available everywhere and accessible to everyone. The company is about to release an innovative portable device, the NanoAnalyzer, designed for the rapid and accurate diagnosis of traumatic brain injuries (TBI) using patient blood samples.
This tool aims to streamline the triage process in emergency settings, allowing healthy patients to be quickly ruled out before being subjected to more expensive and invasive tests, such as CT scans or MRIs. The system consists of a reusable reader, the NanoAnalyzer, disposable cartridges containing the patented chip, and AI-based algorithms for data analysis. The technology behind this device utilizes nano-acoustics, an innovative methodology that employs ultra-high frequency acoustic waves to precisely detect key biomarkers, such as GFAP protein, an indicator of brain injury.
The NanoAnalyzer is designed for use in various settings, from ambulances to war zones, hospitals, and remote areas. Its versatility also makes it suitable for other sectors, such as environmental monitoring and food safety. The technology's key advantages include portability, multiplex analysis capability, speed, and low cost, positioning it between low-cost rapid tests and high-precision, expensive, non-portable laboratory tests.